Correlation Between C4 Therapeutics and GRI Bio
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and GRI Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and GRI Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and GRI Bio, you can compare the effects of market volatilities on C4 Therapeutics and GRI Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of GRI Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and GRI Bio.
Diversification Opportunities for C4 Therapeutics and GRI Bio
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between CCCC and GRI is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and GRI Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GRI Bio and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with GRI Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GRI Bio has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and GRI Bio go up and down completely randomly.
Pair Corralation between C4 Therapeutics and GRI Bio
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 0.64 times more return on investment than GRI Bio. However, C4 Therapeutics is 1.57 times less risky than GRI Bio. It trades about -0.1 of its potential returns per unit of risk. GRI Bio is currently generating about -0.09 per unit of risk. If you would invest 533.00 in C4 Therapeutics on September 1, 2024 and sell it today you would lose (78.00) from holding C4 Therapeutics or give up 14.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
C4 Therapeutics vs. GRI Bio
Performance |
| Timeline |
| C4 Therapeutics |
| GRI Bio |
C4 Therapeutics and GRI Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and GRI Bio
The main advantage of trading using opposite C4 Therapeutics and GRI Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, GRI Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GRI Bio will offset losses from the drop in GRI Bio's long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
| GRI Bio vs. Werewolf Therapeutics | GRI Bio vs. Edgewise Therapeutics | GRI Bio vs. Celcuity LLC | GRI Bio vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets |